Camp4 Therapeutics Corporation (CAMP)

NASDAQ: CAMP · Real-Time Price · USD

4.320

-0.160 (-3.57%)

At close: Aug 24, 2026, 4:00 PM EDT

4.400

+0.080 (1.85%)

After-hours: Aug 24, 2026, 7:30 PM EDT

Camp4 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	86.4	109.52	64.04	38.38	83.19
Cash & Short-Term Investments	86.4	109.52	64.04	38.38	83.19
Cash Growth	121.24%	71.02%	66.86%	-53.86%	-
Accounts Receivable	-	0.16	-	-	-
Other Receivables	0.22	-	0.11	0.44	0.68
Receivables	0.22	0.16	0.11	0.44	0.68
Prepaid Expenses	0.21	0.56	0.59	0.36	0.16
Restricted Cash	0.73	1.35	-	-	-
Other Current Assets	2.47	2.52	1.65	0.83	0.38
Total Current Assets	90.03	114.1	66.38	40.01	84.41
Property, Plant & Equipment	2.44	2.74	9.87	13.31	16.79
Other Long-Term Assets	0.96	0.98	2.05	1.62	1.35
Total Assets	93.43	117.81	78.31	54.95	102.55

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	1.09	0.18	1.21	1.04	2.15
Accrued Expenses	3.18	5.54	4.3	3.01	3.17
Current Portion of Long-Term Debt	-	0.03	0.18	0.41	-
Current Portion of Leases	0.8	0.29	2.99	3.06	2.37
Current Unearned Revenue	13.01	9.39	0.39	-	-
Other Current Liabilities	1.06	0.09	0.54	0.29	0.26
Total Current Liabilities	19.14	15.51	9.6	7.81	7.95
Long-Term Debt	-	-	-	0.09	-
Long-Term Leases	1.57	1.69	5.49	8.64	10.03
Long-Term Unearned Revenue	1.5	8.11	-	-	-
Other Long-Term Liabilities	71.91	44.79	0.07	0	-0.04
Total Liabilities	94.12	70.1	15.16	16.53	17.93

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0.01	0.01	0	0	0
Additional Paid-In Capital	343.32	339.85	274.9	36.23	33.14
Retained Earnings	-344.02	-292.16	-211.75	-159.96	-110.67
Total Common Equity	-0.69	47.7	63.14	-123.73	-77.53
Shareholders' Equity	-0.69	47.7	63.14	38.42	84.62
Total Liabilities & Equity	93.43	117.81	78.31	54.95	102.55

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	2.37	2	8.66	12.18	12.4
Net Cash (Debt)	84.03	107.52	55.38	26.2	70.8
Net Cash Growth	163.97%	94.16%	111.38%	-63.00%	-
Net Cash Per Share	1.71	3.54	11.81	66.33	226.69
Filing Date Shares Outstanding	62.75	51.92	20.15	0.46	0.31
Total Common Shares Outstanding	51.93	51.9	20.15	0.46	0.31
Working Capital	70.89	98.58	56.79	32.21	76.46
Book Value Per Share	-0.01	0.92	3.13	-268.57	-248.26
Tangible Book Value	-0.69	47.7	63.14	-123.73	-77.53
Tangible Book Value Per Share	-0.01	0.92	3.13	-268.57	-248.26
Machinery	5.67	5.57	5.57	4.78	4.17
Leasehold Improvements	4.52	4.52	4.52	4.52	4.52

SEC Filings: 10-K · 10-Q